Table 5.
Right and left ventricular variables before and after inhalation of milrinone
| Before milrinone inhalation | After milrinone inhalation | P-value | |
|---|---|---|---|
| RV-strain (-%) | 20.5 ± 3.7 | 23.2 ± 4.6 | 0.268 |
| FAC (%) | 36.2 ± 11.0 | 31.2 ± 7.4 | 0.127 |
| TAPSE (cm) | 1.9 ± 0.4 | 2.1 ± 0.5 | 0.265 |
| RV s’ (cm/s) | 12.6 ± 1.1 | 12.8 ± 1.6 | 0.871 |
| AT (ms) | 78.4 ± 11.8 | 73.4 ± 13.4 | 0.381 |
| RV-diameter (cm) | 4.4 ± 0.7 | 4.1 ± 0.3 | 0.218 |
| RVEDA index (cm2/m2) | 12.3 ± 1.6 | 12.0 ± 2.5 | 0.652 |
| TVG (mm Hg) | 42.8 ± 7.6 | 41.5 ± 14.4 | 0.851 |
| SPAP (mm Hg) | 55.7 ± 10.1 | 52.4 ± 16.4 | 0.680 |
| CI (L/m2) | 2.5 ± 0.4 | 2.8 ± 0.6 | 0.263 |
| LVEF (%) | 62.8 ± 8.2 | 55.0 ± 11.4 | 0.237 |
| LV GLS (-%) | 18.0 ± 2.6 | 18.8 ± 2.9 | 0.289 |
Data are presented as mean ± SD. Abbreviations as in Table 4. CI, cardiac index; LV, left ventricular; RVEDA index, right ventricular end-diastolic area indexed to body surface area; LVEF, Left ventricular ejection fraction; LV GLS, left ventricular global longitudinal strain.